Skip to main content
. 2021 Aug 2;62(3):432–448. doi: 10.1007/s12016-021-08877-y

Table 2.

Comparison of grading systems

Grading system and application Grade/severity and definitions
CTCAE v5.0* for infusion-related reactions [29]

Grade 1

Mild transient reaction

Infusion interruption not indicated

Intervention not indicated

Grade 2

Therapy or infusion interruption indicated but responds promptly to symptomatic treatment (e.g., antihistamines, NSAIDs, opioids, intravenous fluids)

Grade 3

Prolonged (e.g., not rapidly responsive to symptomatic medication and/or brief interruption of infusion)

Recurrence of symptoms following initial improvement

Hospitalization indicated for other clinical sequelae

Grade 4

Life-threatening consequences

Urgent intervention indicated

Brown grading system for general HSRs [30]

Grade 1 (mild)

Skin and subcutaneous tissues only, e.g., generalized erythema, urticaria, periorbital edema, or angioedema

Grade 2 (moderate)

Features suggesting respiratory, cardiovascular, or gastrointestinal organ involvement, e.g., dyspnea, stridor, wheeze, nausea, vomiting, dizziness (presyncope), diaphoresis, chest or throat tightness, or abdominal pain

Grade 3 (severe)

Hypoxia, hypotension, or neurological organ compromise, i.e., cyanosis or SpO2 ≤ 92% at any stage, hypotension (SBP < 90 mmHg in adults), confusion, collapse, LOC, or incontinence

Brown grading system, example of adaptation for taxane HSRs [32]

Grade 1 (mild)

Symptoms limited to the skin (e.g., flushing) or involve a single organ/system and are mild (e.g., mild back pain)

Grade 2 (moderate)

Symptoms involve at least 2 organs/systems (e.g., flushing and dyspnea), but there is no significant decrease in blood pressure or oxygen saturation

Grade 3 (severe)

Symptoms typically involve at least 2 organs/systems, and there is a significant decrease in blood pressure (systolic ≤ 90 mm Hg and/or syncope) and/or oxygen saturation (≤ 92%)

*CTCAE also includes grade 5 which is death